Showing results (2681-2690 of 6,239) with videos related to
Sort By:
Pageof 624
Nature Medicine|April 28, 2026
AI framework for multidisease detection via retinal imagingXiayin Zhang, Qinyi Li, Yinhao Liang, et al.Nature Medicine|May 10, 2026
Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trialD J van Veldhuisen, M Rienstra, A Mosterd, et al.Nature Medicine|April 7, 2026
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trialGerald F Watts, Russell Scott, David Sullivan, et al.Nature Medicine|April 15, 2026
Rapid expansion of genotype D1.1 A(H5N1) influenza viruses in wild birds across North America during the 2024 migratory seasonWalter N Harrington, Anthony Signore, Lisa Kercher, et al.Nature Medicine|May 15, 2026
Population-scale genomic medicine with the Hong Kong Genome ProjectDingge Ying, Ching-Lung Cheung, Chun-Kwan O, et al.Nature Medicine|May 12, 2026
Genomic epidemiology of the 2025 mpox epidemic in Sierra LeoneAllan K O Campbell, John Demby Sandi, Ifeanyi F Omah, et al.Nature Medicine|February 27, 2026
Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trialStephen J Nicholls, Adam J Nelson, Marc Ditmarsch, et al.Nature Medicine|February 27, 2026
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trialJan-Jaap J Mellema, Chantal F Stockem, Cameron Herberts, et al.Nature Medicine|February 9, 2026
Reliability of LLMs as medical assistants for the general public: a randomized preregistered studyAndrew M Bean, Rebecca Elizabeth Payne, Guy Parsons, et al.Nature Medicine|March 3, 2026
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trialPing Wan, Siyuan Tang, Dongni Lin, et al.Pageof 624